Yousif Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Yousif Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Sell	42,423 -8,301	-16%	-$276K	0.02%	845
2026 Q1	$1.53M	Sell	50,724 -7,300	-13%	-$235K	0.02%	820
2025 Q4	$1.82M	Hold	58,024	–	–	0.02%	757
2025 Q3	$1.17M	Sell	58,024 -792	-1%	-$13.9K	0.01%	1013
2025 Q2	$986K	Buy	58,816 +2,830	+5%	+$45.7K	0.01%	1131
2025 Q1	$861K	Buy	55,986 +1,033	+2%	+$18.5K	0.01%	1181
2024 Q4	$1.21M	Buy	54,953 +1,872	+4%	+$34.1K	0.01%	1039
2024 Q3	$957K	Hold	53,081	–	–	0.01%	1203
2024 Q2	$863K	Hold	53,081	–	–	0.01%	1215
2024 Q1	$749K	Buy	53,081 +2,400	+5%	+$30.3K	0.01%	1335
2023 Q4	$529K	Hold	50,681	–	–	0.01%	1503
2023 Q3	$517K	Sell	50,681 -365	-0.7%	-$3.4K	0.01%	1463
2023 Q2	$384K	Buy	51,046 +365	+0.7%	+$2.96K	﹤0.01%	1610
2023 Q1	$449K	Hold	50,681	–	–	0.01%	1537
2022 Q4	$462K	Hold	50,681	–	–	0.01%	1531
2022 Q3	$409K	Hold	50,681	–	–	0.01%	1603
2022 Q2	$381K	Hold	50,681	–	–	0.01%	1652
2022 Q1	$476K	Buy	50,681 +2,425	+5%	+$20.2K	0.01%	1670
2021 Q4	$387K	Buy	+48,256	New	+$436K	﹤0.01%	1744

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Yousif Capital Management's TEVA Position: Q2 2026 in Review

Yousif Capital Management reduced its Teva Pharmaceuticals (TEVA) stake by 16% in Q2 2026, selling an estimated $276K and leaving 42,423 shares worth $1.44M. The position accounts for 0.02% of the portfolio, ranked #845.

Yousif Capital Management first reported a position in TEVA in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.82M in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Yousif Capital Management held 42,423 shares of Teva Pharmaceuticals worth $1.44M as of Q2 2026.
Yousif Capital Management sold 8,301 Teva Pharmaceuticals shares in Q2 2026, an estimated $276K.
Teva Pharmaceuticals made up 0.02% of Yousif Capital Management's portfolio in Q2 2026, its #845 holding.
Yousif Capital Management first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
Yousif Capital Management's Teva Pharmaceuticals position peaked at $1.82M in Q4 2025.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.